Skip to content
Sign inOpen the app
Artwork for The Chain: Protein Engineering Podcast
The Chain: Protein Engineering Podcast · Sep 16, 2025 · 42 min

Episode: 77 - Derek Lowe on AI and the US Biotech Ecosystem

September 16, 2025 | With the rise of AI and automation, what is the core human skill in drug discovery that is and will be valuable in the future? Derek Lowe, director of Chemical Biology Therapeutics at Novartis and author of the In the Pipeline blog, discusses the impact of AI—and non-AI technologies—on the business of drug making. With host Christopher Bahl, cofounder and CEO of AI Proteins, their conversation covers the value of a PhD in the tech world today, the long-term impacts of knowledge creation in US leadership positions, how the industry can navigate a biotech winter, and more. Links from this episode: AI Proteins Novartis In the Pipeline

0:00 · Introduction to Derek Lowe-42:25
Play in podnodTranscript file

transcript

No transcript — this publisher did not publish one.

show notes

September 16, 2025 | With the rise of AI and automation, what is the core human skill in drug discovery that is and will be valuable in the future? Derek Lowe, director of Chemical Biology Therapeutics at Novartis and author of the In the Pipeline blog, discusses the impact of AI—and non-AI technologies—on the business of drug making. With host Christopher Bahl, cofounder and CEO of AI Proteins, their conversation covers the value of a PhD in the tech world today, the long-term impacts of knowledge creation in US leadership positions, how the industry can navigate a biotech winter, and more. 

Links from this episode:  
AI Proteins
Novartis 
In the Pipeline 

links3

chapters

8 chapters

more episodes

All episodes